23 days ago
Celebrity birthdays for the week of Oct. 11-17:
Oct. 11: Country singer Gene Watson is 83. Singer Daryl Hall of Hall and Oates is 80. Actor Catlin Adams ("The Jerk," "The Jazz Singer") is 76. Country singer Paulette Carlson (Highway 101) is 75. MTV VJ Mark Goodman is 74. Actor David Morse ("St. Elsewhere") is 73. Actor Stephen Spinella ("24") is 70. Actor Joan Cusack is 64. Guitarist Scott Johnson of Gin Blossoms is 64. Actor-writer Michael J. Nelson ("Mystery Science Theater 3000") is 62. Actor Sean Patrick Flanery is 61. Actor Lennie James ("The Walking Dead") is 61. Musician Todd Snider is 60. Actor Artie Lange ("MADtv") is 59. Actor Jane Krakowski ("30 Rock," "Ally McBeal") is 58. Actor Andrea Navedo ("Jane the Virgin") is 57. Rapper MC Lyte is 56. Actor Constance Zimmer ("UnREAL," "Agents of S.H.I.E.L.D.") is 56. Actor Darien Sills-Evans ("Superior Donuts," "Treme") is 52. Singer NeeNa Lee is 51. Actor Emily Deschanel ("Bones") is 50. Actor Trevor Donovan ("90210") is 48. Rapper Cardi B is 34.
Oct. 13: Gospel singer Shirley Caesar is 89. Musician Paul Simon is 85. Keyboardist Robert Lamm of Chicago is 82. Country singer Lacy J. Dalton is 80. Singer Sammy Hagar is 79. Singer John Ford Coley of England Dan and John Ford Coley is 78. Model Beverly Johnson is 74. Actor John Lone ("The Last Emperor," "Rush Hour 2") is 74. "The X-Files" creator Chris Carter is 70. Singer Cherrelle is 67. Singer-actor-talk show host Marie Osmond is 67. Singer Joey Belladonna of Anthrax is 66. Actor T'Keyah Crystal Keymah ("That's So Raven," "In Living Color") is 64. Country singer John Wiggins is 64. Actor Christopher Judge (TV's "Stargate SG-1") is 62. Actor Matt Walsh ("Veep") is 62. Actor Reginald Ballard ("Martin," "The Bernie Mac Show") is 61. Actor Kate Walsh ("Private Practice," "Grey's Anatomy") is 59. Musician Jeff Allen of Mint Condition is 58. Actor Tisha Campbell-Martin ("My Wife and Kids," "Martin") is 58. Country singer Rhett Akins is 57. TV personality Billy Bush is 55. Actor Sacha Baron Cohen ("Borat," "Da Ali G Show") is 55. Guitarist Jan Van Sichem Jr. of K's Choice is 54. Singers Brandon and Brian Casey of Jagged Edge are 51. Actor Kiele Sanchez ("Lost") is 50. Singer Ashanti is 46. Singer-rapper Lumidee is 46. Contemporary Christian singer Jon Micah Sumrall of Kutless is 46. Actor Caleb McLaughlin ("Stranger Things") is 25.
Oct. 14: Director Carroll Ballard ("The Black Stallion") is 89. Singer Cliff Richard is 86. Singer Justin Hayward of the Moody Blues is 80. Actor Greg Evigan ("My Two Dads," "B.J. and the Bear") is 73. Singer Thomas Dolby is 68. Actor Lori Petty ("A League of Their Own") is 63. Actor Steve Coogan ("Night at the Museum" movies) is 61. Singer Karyn White is 61. Actor Edward Kerr ("Pretty Little Liars," "Snoops") is 60. Actor Jon Seda ("Chicago P.D.," "Homicide: Life on the Street") is 56. Bassist Doug Virden (Sons of the Desert) is 56. Country singer Natalie Maines of The Chicks is 52. Singer Shaznay Lewis of All Saints is 5
Oct. 11: Country singer Gene Watson is 83. Singer Daryl Hall of Hall and Oates is 80. Actor Catlin Adams ("The Jerk," "The Jazz Singer") is 76. Country singer Paulette Carlson (Highway 101) is 75. MTV VJ Mark Goodman is 74. Actor David Morse ("St. Elsewhere") is 73. Actor Stephen Spinella ("24") is 70. Actor Joan Cusack is 64. Guitarist Scott Johnson of Gin Blossoms is 64. Actor-writer Michael J. Nelson ("Mystery Science Theater 3000") is 62. Actor Sean Patrick Flanery is 61. Actor Lennie James ("The Walking Dead") is 61. Musician Todd Snider is 60. Actor Artie Lange ("MADtv") is 59. Actor Jane Krakowski ("30 Rock," "Ally McBeal") is 58. Actor Andrea Navedo ("Jane the Virgin") is 57. Rapper MC Lyte is 56. Actor Constance Zimmer ("UnREAL," "Agents of S.H.I.E.L.D.") is 56. Actor Darien Sills-Evans ("Superior Donuts," "Treme") is 52. Singer NeeNa Lee is 51. Actor Emily Deschanel ("Bones") is 50. Actor Trevor Donovan ("90210") is 48. Rapper Cardi B is 34.
Oct. 13: Gospel singer Shirley Caesar is 89. Musician Paul Simon is 85. Keyboardist Robert Lamm of Chicago is 82. Country singer Lacy J. Dalton is 80. Singer Sammy Hagar is 79. Singer John Ford Coley of England Dan and John Ford Coley is 78. Model Beverly Johnson is 74. Actor John Lone ("The Last Emperor," "Rush Hour 2") is 74. "The X-Files" creator Chris Carter is 70. Singer Cherrelle is 67. Singer-actor-talk show host Marie Osmond is 67. Singer Joey Belladonna of Anthrax is 66. Actor T'Keyah Crystal Keymah ("That's So Raven," "In Living Color") is 64. Country singer John Wiggins is 64. Actor Christopher Judge (TV's "Stargate SG-1") is 62. Actor Matt Walsh ("Veep") is 62. Actor Reginald Ballard ("Martin," "The Bernie Mac Show") is 61. Actor Kate Walsh ("Private Practice," "Grey's Anatomy") is 59. Musician Jeff Allen of Mint Condition is 58. Actor Tisha Campbell-Martin ("My Wife and Kids," "Martin") is 58. Country singer Rhett Akins is 57. TV personality Billy Bush is 55. Actor Sacha Baron Cohen ("Borat," "Da Ali G Show") is 55. Guitarist Jan Van Sichem Jr. of K's Choice is 54. Singers Brandon and Brian Casey of Jagged Edge are 51. Actor Kiele Sanchez ("Lost") is 50. Singer Ashanti is 46. Singer-rapper Lumidee is 46. Contemporary Christian singer Jon Micah Sumrall of Kutless is 46. Actor Caleb McLaughlin ("Stranger Things") is 25.
Oct. 14: Director Carroll Ballard ("The Black Stallion") is 89. Singer Cliff Richard is 86. Singer Justin Hayward of the Moody Blues is 80. Actor Greg Evigan ("My Two Dads," "B.J. and the Bear") is 73. Singer Thomas Dolby is 68. Actor Lori Petty ("A League of Their Own") is 63. Actor Steve Coogan ("Night at the Museum" movies) is 61. Singer Karyn White is 61. Actor Edward Kerr ("Pretty Little Liars," "Snoops") is 60. Actor Jon Seda ("Chicago P.D.," "Homicide: Life on the Street") is 56. Bassist Doug Virden (Sons of the Desert) is 56. Country singer Natalie Maines of The Chicks is 52. Singer Shaznay Lewis of All Saints is 5
24 days ago
More than two years after Selma Blair posted a comment widely criticized as Islamophobic, for which she later apologized, the actress has revealed the alleged repercussions she experienced in her career and personal life.
The 54-year-old said in a speech on Oct. 1 that she felt "erased" after losing partnerships, legal and career representation and a "best friend" over the February 2024 comment.
The speech took place at the Anti-Defamation League's event at the Jewish Museum in New York City, which celebrated the launch of the organization's State of the Arts: Advancing Jewish Inclusion in Arts, Entertainment and Culture platform.
In the since-deleted message, the "Cruel Intentions" star had issued a call to "deport all these terrorist supporting goons" under a video describing former U.S. Rep. Cori Bush and Rep. Rashida Tlaib as "Jew hating antisemites" for voting against legislation that would have imposed sanctions against people, agencies and governments that "assist Hamas, the Palestinian Islamic Jihad or their affiliates."
"The brands I worked with were gone within a day. A few partnerships I'd spent years building were shelved. My agency was gone. My lawyer was gone. My publicist was gone. My book agent was gone. My book publicist was gone. My social media manager was gone. My son's godmother was gone – my best friend," Blair said from the podium.
#blair #jewish #Career #partnerships
The 54-year-old said in a speech on Oct. 1 that she felt "erased" after losing partnerships, legal and career representation and a "best friend" over the February 2024 comment.
The speech took place at the Anti-Defamation League's event at the Jewish Museum in New York City, which celebrated the launch of the organization's State of the Arts: Advancing Jewish Inclusion in Arts, Entertainment and Culture platform.
In the since-deleted message, the "Cruel Intentions" star had issued a call to "deport all these terrorist supporting goons" under a video describing former U.S. Rep. Cori Bush and Rep. Rashida Tlaib as "Jew hating antisemites" for voting against legislation that would have imposed sanctions against people, agencies and governments that "assist Hamas, the Palestinian Islamic Jihad or their affiliates."
"The brands I worked with were gone within a day. A few partnerships I'd spent years building were shelved. My agency was gone. My lawyer was gone. My publicist was gone. My book agent was gone. My book publicist was gone. My social media manager was gone. My son's godmother was gone – my best friend," Blair said from the podium.
#blair #jewish #Career #partnerships
26 days ago
Gene Simmons and Shannon Tweed-Simmons married in 2011 after nearly three decades of dating
The couple, who share two adult children, commemorated their 15th wedding anniversary on Oct. 1 with heartfelt social media posts
"She is the love, life, and moral compass of our family. Without her, I'm sure I would have been an empty shell of a man," the KISS rocker wrote in part
Gene Simmons is celebrating 15 years of marriage.
The KISS bassist and co-vocalist, 77, married his longtime love, Shannon Tweed-Simmons, in 2011 after 28 years together, and they renewed their vows a few years later. The couple celebrated the 15th anniversary of their first wedding celebration in heartfelt posts on social media on Thursday, Oct. 1.
#shannon #kiss #wedding
The couple, who share two adult children, commemorated their 15th wedding anniversary on Oct. 1 with heartfelt social media posts
"She is the love, life, and moral compass of our family. Without her, I'm sure I would have been an empty shell of a man," the KISS rocker wrote in part
Gene Simmons is celebrating 15 years of marriage.
The KISS bassist and co-vocalist, 77, married his longtime love, Shannon Tweed-Simmons, in 2011 after 28 years together, and they renewed their vows a few years later. The couple celebrated the 15th anniversary of their first wedding celebration in heartfelt posts on social media on Thursday, Oct. 1.
#shannon #kiss #wedding
26 days ago
Brooke Eby, the beloved activist who documented her battle with ALS for millions of people online, has died. She was 37. Eby's longtime advocacy partner group ALS Network announced the news on Oct. 1.
"Brooke changed the way people see ALS, but she also changed the way people living with ALS find and support one another," said Sheri Strahl, president and CEO of the ALS Network. "She brought humor into incredibly difficult moments, spoke with fearless honesty, and created connection where it was desperately needed. We are heartbroken by her passing and profoundly grateful that we had the privilege of knowing her, working alongside her, and celebrating her. Brooke's impact will live on in every person she reached and throughout the community she created."
More from Rolling Stone
Conrad 'Cronos' Lant, Singer and Bassist of Black Metal Pioneers Venom, Dead at 63
Dennis Haskins, Mr. Belding on 'Saved by the Bell,' Dead at 75
#created
"Brooke changed the way people see ALS, but she also changed the way people living with ALS find and support one another," said Sheri Strahl, president and CEO of the ALS Network. "She brought humor into incredibly difficult moments, spoke with fearless honesty, and created connection where it was desperately needed. We are heartbroken by her passing and profoundly grateful that we had the privilege of knowing her, working alongside her, and celebrating her. Brooke's impact will live on in every person she reached and throughout the community she created."
More from Rolling Stone
Conrad 'Cronos' Lant, Singer and Bassist of Black Metal Pioneers Venom, Dead at 63
Dennis Haskins, Mr. Belding on 'Saved by the Bell,' Dead at 75
#created
1 month ago
Apollo Global Management, Inc. (NYSE:APO) is reportedly in talks to acquire Johnson & Johnson (NYSE:JNJ) DePuy Synthes orthopedics business in a transaction that could value the unit at close to $20 billion, according to Bloomberg, as reported by Reuters. J&J generated $9.3 billion of revenue from the orthopedics business in 2025, making the potential transaction material for both companies. The discussions could reach an agreement within weeks, although J&J is also considering a public-market spin-off. This is consistent with J&J's October 2025 decision to separate DePuy Synthes within an expected 18-to-24-month timeframe and shift its MedTech portfolio toward higher-growth, higher-margin businesses.
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of ***** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#billion #depuy
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of ***** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#billion #depuy
1 month ago
Apollo Global Management, Inc. (NYSE:APO) is reportedly in talks to acquire Johnson & Johnson (NYSE:JNJ) DePuy Synthes orthopedics business in a transaction that could value the unit at close to $20 billion, according to Bloomberg, as reported by Reuters. J&J generated $9.3 billion of revenue from the orthopedics business in 2025, making the potential transaction material for both companies. The discussions could reach an agreement within weeks, although J&J is also considering a public-market spin-off. This is consistent with J&J's October 2025 decision to separate DePuy Synthes within an expected 18-to-24-month timeframe and shift its MedTech portfolio toward higher-growth, higher-margin businesses.
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of **** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#NYSE #johnson
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of **** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#NYSE #johnson
2 months ago
On the latest episode of BBC Radio Leeds' Don't Go To Bed Just Yet, reporter and commentator Adam Pope was alongside Jonny Buchan and Kaiser Chiefs' bassist Simon Rix to discuss his recent chat with the Whites managing director Robbie Evans.
Pope said: "He [Evans] spoke for the best part of an hour to the local press. The mood was really good, as you'd expect because they'd instigated this sit-down on the back of the window, so I think it's fair to say the mood was 'look, we're on the back of a really good window'.
"It was a good window and a good deadline day. That was the context in which this was done."
Pope said one of the key headlines was the discussion around Daniel Farke's contract situation, on which Rix added: "I think it'd be naive to think there have never been any negotiations.
"I've said that I didn't think it was a worry that it hasn't been signed, even with the year left. I don't think that's a problem."
#think #evans #really
Pope said: "He [Evans] spoke for the best part of an hour to the local press. The mood was really good, as you'd expect because they'd instigated this sit-down on the back of the window, so I think it's fair to say the mood was 'look, we're on the back of a really good window'.
"It was a good window and a good deadline day. That was the context in which this was done."
Pope said one of the key headlines was the discussion around Daniel Farke's contract situation, on which Rix added: "I think it'd be naive to think there have never been any negotiations.
"I've said that I didn't think it was a worry that it hasn't been signed, even with the year left. I don't think that's a problem."
#think #evans #really
2 months ago
When a subject has been as exhaustively covered — and as infamous — as Elon Musk, the electric-car-entrepreneur-turned-rocket-man-turned-richest-billionaire-in-the-universe-turned-Twitter-disruptor-turned-DOGE-destroyer-turned-God-only-knows-what-he'll-do-next, reviews of a documentary about him tend to lead by plucking out the film's incendiary bits of investigative reportage, the ones that feel worthy of a news headline. "Musk," Alex Gibney's 3-hour-and-45-minute documentary about the tech bro who would be king, has a handful of those.
The biggest revelation, to me, was the film's detailed history of Musk's attempt to put a self-driving car on the market — a technology that's sure to be here at some point, though Musk, in his race to be first, was far too eager to announce that it had already happened. Tesla released its Autopilot driver-assist system in 2015 (and then the Full Self-Driving Beta program in 2020), marketing the new technology with ads that exaggerated the car's powers. And so people were suckered. From the outset, there were accidents. More than 60 fatalities have been linked to Tesla's driver-assistance systems. Talk about something that could put a dent in your image! But Musk, for the most part, succeeded in hushing up the lawsuits, the federal investigations, and the fatal crashes, which were evidence of a recklessness that should have given the whole world pause.
More from Variety
Elon Musk's Ex Ashley St. Clair on Rejecting a $40 Million NDA and Participating in 'Musk' Doc: 'I Hope the Risk in Trying to Fight Back Helps a Little Bit'
Elon Musk Documentary Teaser Asks If Billionaire Is the 'Greatest Living Inventor' or a 'Fascist' Who 'Has Lost His Mind'
#twitter
The biggest revelation, to me, was the film's detailed history of Musk's attempt to put a self-driving car on the market — a technology that's sure to be here at some point, though Musk, in his race to be first, was far too eager to announce that it had already happened. Tesla released its Autopilot driver-assist system in 2015 (and then the Full Self-Driving Beta program in 2020), marketing the new technology with ads that exaggerated the car's powers. And so people were suckered. From the outset, there were accidents. More than 60 fatalities have been linked to Tesla's driver-assistance systems. Talk about something that could put a dent in your image! But Musk, for the most part, succeeded in hushing up the lawsuits, the federal investigations, and the fatal crashes, which were evidence of a recklessness that should have given the whole world pause.
More from Variety
Elon Musk's Ex Ashley St. Clair on Rejecting a $40 Million NDA and Participating in 'Musk' Doc: 'I Hope the Risk in Trying to Fight Back Helps a Little Bit'
Elon Musk Documentary Teaser Asks If Billionaire Is the 'Greatest Living Inventor' or a 'Fascist' Who 'Has Lost His Mind'
2 months ago
On August 21, Kurt Yinger from DA Davidson initiated his coverage of Everus Construction Group Inc. (NYSE:ECG) with a $168 target price and an upside potential of more than 43%, as of September 4 closing. The **** yst **** igned a Buy rating to the stock based on a highly compelling story that revolves around recent accretive acquisitions, expanding profit margins, lucrative project backlog, and strong order bookings. Kurt anticipated the $295 million Epsilon acquisition to bolster the existing forecasts. Let's explore what fuels this bullish narrative around this specialty contractor.
youssef-abdelwahab-qyzo7TDSVQs-unsplash
Everus finalized its $295 million cash acquisition of Epsilon Industries on September 1. Epsilon is an established designer and manufacturer of mechanical and electrical building infrastructure systems. The transaction was financed using a mix of cash on hand and borrowings under the company's existing credit facilities.
The deal expands Everus' prefabrication and modular construction capabilities, enabling it to cater to high-demand sectors through custom fabrication, design-assist and turnkey installation solutions. These sectors include data centers, advanced manufacturing, and healthcare. Epsilon's numerous strategic centers in the U.S. and Canada will contribute to Everus' nationwide distribution network and augment its current geographic presence within priority growth markets.
By integrating Epsilon's workforce and technical expertise, Everus is well-positioned to meet the increased customer demand, penetrate key end-markets and capitalize on favorable industry trends. With this the company will ultimately reinforce its competitive edge and long-term growth trajectory within the construction sector.
#everus
youssef-abdelwahab-qyzo7TDSVQs-unsplash
Everus finalized its $295 million cash acquisition of Epsilon Industries on September 1. Epsilon is an established designer and manufacturer of mechanical and electrical building infrastructure systems. The transaction was financed using a mix of cash on hand and borrowings under the company's existing credit facilities.
The deal expands Everus' prefabrication and modular construction capabilities, enabling it to cater to high-demand sectors through custom fabrication, design-assist and turnkey installation solutions. These sectors include data centers, advanced manufacturing, and healthcare. Epsilon's numerous strategic centers in the U.S. and Canada will contribute to Everus' nationwide distribution network and augment its current geographic presence within priority growth markets.
By integrating Epsilon's workforce and technical expertise, Everus is well-positioned to meet the increased customer demand, penetrate key end-markets and capitalize on favorable industry trends. With this the company will ultimately reinforce its competitive edge and long-term growth trajectory within the construction sector.
#everus
2 months ago
From identifying major life changes like a shopper's marriage or a recent pay ******* p, artificial intelligence is enabling marketers to learn more about consumers in a way that is almost too intimate.
A new report from Coresight Research offers a glimpse into how extensive data gathering has become for brands and retailers, and how the latest advancements in AI can further expand insights.
More from WWD
What If Behind Every Successful Fortune 500 Executive Is An AI 'Super Agent'?
Better Cotton, Avalo Bring AI-Assisted Breeding to Texas Farms
#every #fortune #agent
A new report from Coresight Research offers a glimpse into how extensive data gathering has become for brands and retailers, and how the latest advancements in AI can further expand insights.
More from WWD
What If Behind Every Successful Fortune 500 Executive Is An AI 'Super Agent'?
Better Cotton, Avalo Bring AI-Assisted Breeding to Texas Farms
#every #fortune #agent
2 months ago
Revolution Medicines, Inc. (NASDAQ:RVMD) received FDA approval for Rasonque, or daraxonrasib, following an expedited review. The once-daily oral RAS inhibitor is approved for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.
Revolution Medicines, Inc. (NASDAQ:RVMD) set a wholesale acquisition cost (WAC) of $39,800 for a 30-day supply. Twelve 30-day supplies would total $477,600 at WAC before discounts, rebates, or ******* istance. Rasonque is available in the United States, with (ON)Path offering insurance navigation and financial-assistance resources, including copay support for eligible commercially insured patients.
The approval was based on RASolute 302, a randomized Phase 3 trial involving 500 patients with previously treated metastatic pancreatic adenocarcinoma. In the overall population, median overall survival reached 13.2 months with Rasonque versus 6.7 months with chemotherapy. The hazard ratio of 0.40 represented a 60% lower hazard of death during trial follow-up. Median progression-free survival was 7.2 months versus 3.6 months, while objective response rates were 30% and 11%, respectively.
The survival benefit gives Rasonque a strong clinical argument for reimbursement. Pancreatic cancer is aggressive, treatment options after progression are limited, and Rasonque improved overall survival, progression-free survival, and response rates in a randomized comparison. Oral dosing may also reduce the burden of intravenous chemotherapy.
The approved population is broader than a single mutation-defined subgroup. Rasonque can be prescribed with or without an identified RAS tumor mutation and does not require a companion diagnostic. That reduces testing friction within the approved treatment setting.
#months #pancreatic #progression #medicines
Revolution Medicines, Inc. (NASDAQ:RVMD) set a wholesale acquisition cost (WAC) of $39,800 for a 30-day supply. Twelve 30-day supplies would total $477,600 at WAC before discounts, rebates, or ******* istance. Rasonque is available in the United States, with (ON)Path offering insurance navigation and financial-assistance resources, including copay support for eligible commercially insured patients.
The approval was based on RASolute 302, a randomized Phase 3 trial involving 500 patients with previously treated metastatic pancreatic adenocarcinoma. In the overall population, median overall survival reached 13.2 months with Rasonque versus 6.7 months with chemotherapy. The hazard ratio of 0.40 represented a 60% lower hazard of death during trial follow-up. Median progression-free survival was 7.2 months versus 3.6 months, while objective response rates were 30% and 11%, respectively.
The survival benefit gives Rasonque a strong clinical argument for reimbursement. Pancreatic cancer is aggressive, treatment options after progression are limited, and Rasonque improved overall survival, progression-free survival, and response rates in a randomized comparison. Oral dosing may also reduce the burden of intravenous chemotherapy.
The approved population is broader than a single mutation-defined subgroup. Rasonque can be prescribed with or without an identified RAS tumor mutation and does not require a companion diagnostic. That reduces testing friction within the approved treatment setting.
#months #pancreatic #progression #medicines
2 months ago
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.
Intuitive Surgical (ISRG), the pioneer of robotic-assisted surgery, trades around $370, a share after a tough year. The stock has delivered a -21% return over the last twelve months, badly trailing the S&P 500's +19.2% gain. Yet, within its peer group, it commands the highest valuation. Why does the market charge a top-tier price for the company with the group's worst-performing stock?
By the numbers, Intuitive Surgical's operational lead is real, even if Globus Medical sits close behind at 19.7%. The company's revenue grew 21% over the last twelve months, well ahead of diversified rivals like Medtronic, which grew at 8.4%.. Its 31% operating margin also leads the pack, again comfortably ahead of Medtronic's 18.8%. This is a business that executes at a higher level than its competition. The market sees this performance and charges accordingly. Intuitive Surgical trades at 42.5 times earnings, the highest multiple in its group. For comparison, Medtronic trades at a much lower 24.2 times earnings. The mismatch is stark: investors are paying a premium for leading fundamentals, but so far, that premium has not translated into positive returns.
ISRG
MDT
#robotic
Intuitive Surgical (ISRG), the pioneer of robotic-assisted surgery, trades around $370, a share after a tough year. The stock has delivered a -21% return over the last twelve months, badly trailing the S&P 500's +19.2% gain. Yet, within its peer group, it commands the highest valuation. Why does the market charge a top-tier price for the company with the group's worst-performing stock?
By the numbers, Intuitive Surgical's operational lead is real, even if Globus Medical sits close behind at 19.7%. The company's revenue grew 21% over the last twelve months, well ahead of diversified rivals like Medtronic, which grew at 8.4%.. Its 31% operating margin also leads the pack, again comfortably ahead of Medtronic's 18.8%. This is a business that executes at a higher level than its competition. The market sees this performance and charges accordingly. Intuitive Surgical trades at 42.5 times earnings, the highest multiple in its group. For comparison, Medtronic trades at a much lower 24.2 times earnings. The mismatch is stark: investors are paying a premium for leading fundamentals, but so far, that premium has not translated into positive returns.
ISRG
MDT
#robotic
2 months ago
EDITOR'S NOTE: Coaches are reminded to send in game results each weeknight, from 6-10 p.m., by emailing them to pjsportsprovidencejournal.com.
Moses Brown's AlexanderHolland scored an unassisted goal 27 minutes into the first half, and that was the only score in this season-opening contest between the Quakers and Avengers on Wednesday.
In net, Haven Knapp had four saves for Moses Brown, while Brady Parks had three for East Greenwich.
A tight match on the pitch was decided when Morgan Williams scored the Lions' second goal with seven seconds remaining. He was ***** isted by Mason Simpson. Williams ***** isted in the first half on Lincoln's first goal, scored by Jaxon Harris.
Valter Teixeira scored the Warriors' goal in the second half with an ***** ist from captain Kevin Ramos.
#goal #williams #assisted #note
Moses Brown's AlexanderHolland scored an unassisted goal 27 minutes into the first half, and that was the only score in this season-opening contest between the Quakers and Avengers on Wednesday.
In net, Haven Knapp had four saves for Moses Brown, while Brady Parks had three for East Greenwich.
A tight match on the pitch was decided when Morgan Williams scored the Lions' second goal with seven seconds remaining. He was ***** isted by Mason Simpson. Williams ***** isted in the first half on Lincoln's first goal, scored by Jaxon Harris.
Valter Teixeira scored the Warriors' goal in the second half with an ***** ist from captain Kevin Ramos.
#goal #williams #assisted #note
2 months ago
Sunnyvale, California-based Intuitive Surgical, Inc. (ISRG) develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care. Valued at $133.1 billion by market cap, the company offers endoscopes, endoscopic retractors and disectors, scissors, scalpels, forceps, needle holders, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
Companies worth $10 billion or more are generally described as "large-cap stocks," and ISRG definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical instruments & supplies industry. Intuitive Surgical excels in robotic-assisted surgery with its gold-standard da Vinci system, backed by strong brand reputation, continuous R&D investment, and comprehensive surgeon training, driving user proficiency and patient outcomes.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Bill Gates Says 'We Need Time to Prepare' for an Economic Upheaval — Especially the $20-an-Hour Workers Being Replaced by $10-an-Hour Robots
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR
#intuitive #dear
Companies worth $10 billion or more are generally described as "large-cap stocks," and ISRG definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical instruments & supplies industry. Intuitive Surgical excels in robotic-assisted surgery with its gold-standard da Vinci system, backed by strong brand reputation, continuous R&D investment, and comprehensive surgeon training, driving user proficiency and patient outcomes.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Bill Gates Says 'We Need Time to Prepare' for an Economic Upheaval — Especially the $20-an-Hour Workers Being Replaced by $10-an-Hour Robots
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR
#intuitive #dear
2 months ago
Assistant manager Steve Parkin says he understands Chris Wilder's frustrations over the possibility of losing Callum O'Hare to Wrexham after the Sheffield United boss accused the Welsh side of a "blanket bombing" approach to the transfer window.
Speaking ahead of the Blades' Championship contest with Bolton Wanderers at Bramall Lane on Tuesday night (19:45 BST), United boss Wilder confirmed the Red Dragons had submitted a bid for attacking midfielder O'Hare.
During the press briefing, Wilder also said Wrexham were "in for half the division".
And while accepting Wilder's frustrations, Wrexham ****** istant Parkin was keen to stressed his side's transfer dealings are far more methodical than Wilder suggested.
"I did read that (Wilder's comments). Me and Chris go a long way back and he's no different to any other manager," said Parkin.
#chris #o 'hare #manager #boss
Speaking ahead of the Blades' Championship contest with Bolton Wanderers at Bramall Lane on Tuesday night (19:45 BST), United boss Wilder confirmed the Red Dragons had submitted a bid for attacking midfielder O'Hare.
During the press briefing, Wilder also said Wrexham were "in for half the division".
And while accepting Wilder's frustrations, Wrexham ****** istant Parkin was keen to stressed his side's transfer dealings are far more methodical than Wilder suggested.
"I did read that (Wilder's comments). Me and Chris go a long way back and he's no different to any other manager," said Parkin.
#chris #o 'hare #manager #boss
2 months ago
ST. LOUIS (AP) — Logan Farrington scored in the seventh minute of second-half stoppage time to rally FC Dallas to a 3-3 draw with St. Louis City on Sunday night.
St. Louis City (9-6-7) extended its club-record unbeaten streak to 12 under first-year coach Yoann Damet, but missed a chance to move ahead of fifth-place Dallas (9-6-7) in the Western Conference.
Farrington used ****** ists from Petar Musa and Nolan Norris to score the equalizer.
Simon Becher scored unassisted in the 3rd minute to give St. Louis City an early lead. Four of his six goals this season have come in the last four matches.
Dallas pulled even on defender Shaq Moore's first goal of the season — unassisted in the 18th minute. Four of Moore's five career goals have come in his two seasons with the club.
#dallas #four #scored #unassisted
St. Louis City (9-6-7) extended its club-record unbeaten streak to 12 under first-year coach Yoann Damet, but missed a chance to move ahead of fifth-place Dallas (9-6-7) in the Western Conference.
Farrington used ****** ists from Petar Musa and Nolan Norris to score the equalizer.
Simon Becher scored unassisted in the 3rd minute to give St. Louis City an early lead. Four of his six goals this season have come in the last four matches.
Dallas pulled even on defender Shaq Moore's first goal of the season — unassisted in the 18th minute. Four of Moore's five career goals have come in his two seasons with the club.
#dallas #four #scored #unassisted
2 months ago
Sunderland edged Fulham 1-0 at the Stadium of Light in Premier League action, with the only goal of the game arriving in the 75th minute. Wilson Isidor broke the deadlock with a right-footed finish from the centre of the box, after Habib Diarra had supplied the **** ist.
The home side were not dominant in possession, ending the match with 43% to Fulham's 57%, but they were more threatening in the final third. Sunderland registered 11 shots and three on target, compared with Fulham's six attempts and no shots on target, according to the match statistics.
Chance quality also leaned slightly towards Sunderland, who finished with 1.11 expected goals against Fulham's 0.36. The hosts also matched their opponents on corners, with three each, as they made their pressure count when it mattered most.
For Sunderland, the goal marked a first in the competition for Isidor, while Diarra registered his first **** ist. It was enough to secure all three points in a narrow but efficient victory.
Sunderland Official Line-ups:
#isidor #assist #match #target
The home side were not dominant in possession, ending the match with 43% to Fulham's 57%, but they were more threatening in the final third. Sunderland registered 11 shots and three on target, compared with Fulham's six attempts and no shots on target, according to the match statistics.
Chance quality also leaned slightly towards Sunderland, who finished with 1.11 expected goals against Fulham's 0.36. The hosts also matched their opponents on corners, with three each, as they made their pressure count when it mattered most.
For Sunderland, the goal marked a first in the competition for Isidor, while Diarra registered his first **** ist. It was enough to secure all three points in a narrow but efficient victory.
Sunderland Official Line-ups:
#isidor #assist #match #target
2 months ago
On August 27, CIBC (NYSE:CM) reported third-quarter results that pushed adjusted earnings per share to $2.73, up 26% from a year earlier and marking the ninth consecutive quarter of double-digit EPS growth. Adjusted net income climbed to $2,648 million on revenue of $8,368 million, up 15% year over year, and return on equity reached 16.8%, up 260 basis points from the same quarter last year. The headline numbers describe a bank firing on multiple cylinders at once, even as management flagged pockets of strain underneath.
Capital Markets net income grew 34% year over year to $722 million, powered by equity trading and financing activity. Canadian Personal and Business Banking delivered $948 million in net income, up 17% from a year ago, while net interest margin climbed to 304 basis points, up 3 basis points sequentially on higher loan and deposit margins. In the US segment, net income rose 23% to $320 million, helped by lower provisions for loan losses and a revenue increase, even as net interest margin slipped 14 basis points sequentially to 3.76%. CIBC's efficiency ratio tightened by 200 basis points from a year earlier, the 12th straight quarter the bank has generated positive operating leverage, a sign revenue is outrunning costs rather than expenses eating into the gains.
Wealth Management showed similar strength, with ******* ets under administration and ******* ets under management both up more than 20% year over year and credit fees rising 25% on strong corporate lending and financing activity. Investor's Edge, the bank's self-directed investing platform, posted 34% growth in new account openings, and the managed mass affluent client base grew 4%, supporting a 12% increase in money-in balances. CIBC also returned capital to shareholders through 7.5 million shares repurchased during the quarter, and CEO Harry Culham pointed to the newly launched CIBC AI 2.0 agentic workspace and the CIBC AdvisorAssist platform, which he said cuts advisers' administrative documentation time by up to 50%.
Not every line moved in CIBC's favor. The Common Equity Tier 1 ratio slipped 19 basis points sequentially to 13.4%, as organic capital generation was offset by share buybacks and a $269 million charge, $232 million after tax, related to CIBC's planned sale of its Caribbean banking unit, CIBC Caribbean Bank Limited. Provisions on impaired loans climbed $64 million sequentially to $612 million, which CIBC linked to a handful of one-off credit issues inside its Canadian Commercial Banking and Capital Markets books rather than any broader deterioration. Total deposits fell 1% year over year, and GIC balances dropped 10% as clients shifted funds into higher-margin managed mutual fund products.
#income #banking
Capital Markets net income grew 34% year over year to $722 million, powered by equity trading and financing activity. Canadian Personal and Business Banking delivered $948 million in net income, up 17% from a year ago, while net interest margin climbed to 304 basis points, up 3 basis points sequentially on higher loan and deposit margins. In the US segment, net income rose 23% to $320 million, helped by lower provisions for loan losses and a revenue increase, even as net interest margin slipped 14 basis points sequentially to 3.76%. CIBC's efficiency ratio tightened by 200 basis points from a year earlier, the 12th straight quarter the bank has generated positive operating leverage, a sign revenue is outrunning costs rather than expenses eating into the gains.
Wealth Management showed similar strength, with ******* ets under administration and ******* ets under management both up more than 20% year over year and credit fees rising 25% on strong corporate lending and financing activity. Investor's Edge, the bank's self-directed investing platform, posted 34% growth in new account openings, and the managed mass affluent client base grew 4%, supporting a 12% increase in money-in balances. CIBC also returned capital to shareholders through 7.5 million shares repurchased during the quarter, and CEO Harry Culham pointed to the newly launched CIBC AI 2.0 agentic workspace and the CIBC AdvisorAssist platform, which he said cuts advisers' administrative documentation time by up to 50%.
Not every line moved in CIBC's favor. The Common Equity Tier 1 ratio slipped 19 basis points sequentially to 13.4%, as organic capital generation was offset by share buybacks and a $269 million charge, $232 million after tax, related to CIBC's planned sale of its Caribbean banking unit, CIBC Caribbean Bank Limited. Provisions on impaired loans climbed $64 million sequentially to $612 million, which CIBC linked to a handful of one-off credit issues inside its Canadian Commercial Banking and Capital Markets books rather than any broader deterioration. Total deposits fell 1% year over year, and GIC balances dropped 10% as clients shifted funds into higher-margin managed mutual fund products.
#income #banking
2 months ago
SU Group Holdings Limited (NASDAQ:SUGP) has secured exclusive Macao distribution rights for the Inspec Spider robotic infrastructure inspection system, adding a new potential revenue stream to its recently established operation in the region.
The agreement gives subsidiary Shine Union (Macao) Limited sole rights to market, distribute and sell the high-mast inspection technology in Macao, while extending SU Group's portfolio into technology-enabled infrastructure inspection.
SU Group (NASDAQ:SUGP) gains exclusive Macao distribution rights for Inspec Spider during the term of the agreement, creating a new revenue opportunity.
The deal gives the company's new Macao subsidiary an early commercial offering as SU Group works to expand beyond its established Hong Kong operations.
Inspec Spider combines robotics, cameras and AI-assisted ******* ysis to inspect high masts and poles up to 35 metres from ground level.
#macao #NASDAQ
The agreement gives subsidiary Shine Union (Macao) Limited sole rights to market, distribute and sell the high-mast inspection technology in Macao, while extending SU Group's portfolio into technology-enabled infrastructure inspection.
SU Group (NASDAQ:SUGP) gains exclusive Macao distribution rights for Inspec Spider during the term of the agreement, creating a new revenue opportunity.
The deal gives the company's new Macao subsidiary an early commercial offering as SU Group works to expand beyond its established Hong Kong operations.
Inspec Spider combines robotics, cameras and AI-assisted ******* ysis to inspect high masts and poles up to 35 metres from ground level.
#macao #NASDAQ
2 months ago
After a long dry spell, retailer Target (NYSE: TGT) is back on track.
That's the quick takeaway from last quarter's earnings report anyway. The company's same-store sales grew 3.8% year-over-year on a 3.6% improvement in foot traffic for the three months ending in early August, driving total top-line growth of 5.3%, and marking the second strong quarter in a row following yet-another disappointing year ending in early February.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
It's arguably not mere temporary luck either. The strategic turnaround plan unveiled in March has much of what previous plans were missing. That's effective investments in the right opportunities for improvement like more store personnel and smarter merchandise ****** ortment (assisted by artificial intelligence).
Guidance suggests more of the same is in the cards too. Here's what this could mean for investors.
#signal
That's the quick takeaway from last quarter's earnings report anyway. The company's same-store sales grew 3.8% year-over-year on a 3.6% improvement in foot traffic for the three months ending in early August, driving total top-line growth of 5.3%, and marking the second strong quarter in a row following yet-another disappointing year ending in early February.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
It's arguably not mere temporary luck either. The strategic turnaround plan unveiled in March has much of what previous plans were missing. That's effective investments in the right opportunities for improvement like more store personnel and smarter merchandise ****** ortment (assisted by artificial intelligence).
Guidance suggests more of the same is in the cards too. Here's what this could mean for investors.
#signal
2 months ago
ST. LOUIS (AP) — Simon Becher had a first-half goal to end a long scoreless streak by Houston keeper Jonathan Bond, and rookie Dante Polvara added his first MLS goal in the second half as St. Louis City beat the Dynamo 2-1 on Saturday night to extend their club-record unbeaten streak to 11.
Becher hit a turn-around shot from the top of the box in the 23rd minute to halt Jonathan Bond's scoreless streak at 485 minutes and give St. Louis City a 1-0 lead. It was his career-high fifth goal of the campaign.
Ibrahim Aliyu scored for the second time this season, unassisted in the 75th minute to tie it 1-all.
Polvara found the net in the 85th minute unassisted for the victory.
Roman Bürki totaled three saves for St. Louis City, (9-6-6) which has gone 8-0-3 during its unbeaten run.
#louis #streak #jonathan #half
Becher hit a turn-around shot from the top of the box in the 23rd minute to halt Jonathan Bond's scoreless streak at 485 minutes and give St. Louis City a 1-0 lead. It was his career-high fifth goal of the campaign.
Ibrahim Aliyu scored for the second time this season, unassisted in the 75th minute to tie it 1-all.
Polvara found the net in the 85th minute unassisted for the victory.
Roman Bürki totaled three saves for St. Louis City, (9-6-6) which has gone 8-0-3 during its unbeaten run.
#louis #streak #jonathan #half
2 months ago
BEIJING, Aug 21 (Reuters) - Tesla will roll out software fixes for millions of vehicles in China, the country's market regulator said on Monday, marking the automaker's largest-ever recall in the market.
Effective September 25, Tesla will recall 2.98 million China-made and imported Model 3, Model Y, Model S and Model X vehicles because emergency door release handles may be difficult to identify, potentially hindering escape or rescue after a severe crash and electrical system failure. The remedy includes warning labels and an over-the-air (OTA) update that lowers windows after a collision.
Separately, Tesla is immediately recalling 2.74 million China-made Model 3 and Model Y vehicles for an OTA software update to enhance driver-attention monitoring while ******* isted steering and other driver-assistance functions are engaged, reducing the risk of collisions if drivers fail to respond promptly.
(Reporting by Beijing newsroom; Editing by Joe Bavier)
The supertruck arms race is getting petty in the best way possible. With Ram resurrecting the supercharged 777-horsepower TRX SRT and aggressively pushing its 540-hp inline-six Ram 1500 RHO, Ford is making a aggressive move to protect its territory. For the 2027 model year, The Blue Oval has slashed $4,010 off the standard F-150 Raptor's entry sticker, bringing the delivered base price down to $77,790.
#vehicles #beijing #made
Effective September 25, Tesla will recall 2.98 million China-made and imported Model 3, Model Y, Model S and Model X vehicles because emergency door release handles may be difficult to identify, potentially hindering escape or rescue after a severe crash and electrical system failure. The remedy includes warning labels and an over-the-air (OTA) update that lowers windows after a collision.
Separately, Tesla is immediately recalling 2.74 million China-made Model 3 and Model Y vehicles for an OTA software update to enhance driver-attention monitoring while ******* isted steering and other driver-assistance functions are engaged, reducing the risk of collisions if drivers fail to respond promptly.
(Reporting by Beijing newsroom; Editing by Joe Bavier)
The supertruck arms race is getting petty in the best way possible. With Ram resurrecting the supercharged 777-horsepower TRX SRT and aggressively pushing its 540-hp inline-six Ram 1500 RHO, Ford is making a aggressive move to protect its territory. For the 2027 model year, The Blue Oval has slashed $4,010 off the standard F-150 Raptor's entry sticker, bringing the delivered base price down to $77,790.
#vehicles #beijing #made
2 months ago
Caitlin Clark brought an old school vibe to gameday. The WNBA superstar showed off her pregame outfit ahead of the Indiana Fever's matchup with the Dallas Wings.
Clark wore a retro, fitted short-sleeve T-shirt featuring horizontal stripes in shades of mustard yellow, brown, white, navy blue and orange. She paired it with a gold chain necklace and completed her look with her hair styled straight.
MORE: Caitlin Clark draws huge praise from former 2-time WNBA All-Star
The three-time All-Star is coming off a remarkable 29-point, 10-assist performance in the their last game against the Wings on Friday. The double-double marked her 20th career game with at least 20 points and 10 ****** ists.
The Iowa product's retro-inspired pregame look may be a signal of what's to come after tonight's game. After all, Clark likes to repeat history, especially the ones that end with Indiana winning.
#game
Clark wore a retro, fitted short-sleeve T-shirt featuring horizontal stripes in shades of mustard yellow, brown, white, navy blue and orange. She paired it with a gold chain necklace and completed her look with her hair styled straight.
MORE: Caitlin Clark draws huge praise from former 2-time WNBA All-Star
The three-time All-Star is coming off a remarkable 29-point, 10-assist performance in the their last game against the Wings on Friday. The double-double marked her 20th career game with at least 20 points and 10 ****** ists.
The Iowa product's retro-inspired pregame look may be a signal of what's to come after tonight's game. After all, Clark likes to repeat history, especially the ones that end with Indiana winning.
#game
2 months ago
Matt Gulbin may not have fallen immediately asleep Wednesday night.
Gulbin, a rookie out of Michigan State, was drafted by the Commanders in the sixth round, 209th overall, in last April's NFL Draft. Gulbin was selected to bring along and provide depth behind starting center Nick Allegretti.
However, on the very first day of the Commanders' 2026 training camp, Allegretti strained a calf. It was a bad enough strain that Allegretti missed nearly three weeks of training camp practices before returning August 18. Wednesday, Allegretti again had to leave practice early after getting injured.
"I think really, just taking it day-by-day, trying to get better every day," is simply how Gulbin replied to Denton Day when asked Wednesday what he is learning through his first NFL training camp. (I am) taking advantage of everything we do, whether it is practice, walkthroughs or meetings, being in tune and locked in with that."
When asked about the offensive line room, Gulbin quickly responded, "I feel like we have a really good group. Coach Stape, Coach Toub and Coach Stolt do a really good job fostering a good brotherhood. They are down-to-earth, salt-of-the-earth guys. Everybody takes care of each other, which I'm super-grateful for." Gulbin was referring to Darnell Stapleton (Offensive Line Coach), Shane Toub (Assistant Offensive Line Coach) and Brian Stoldt (Offensive Quality Control Coach).
#coach #line #training #camp
Gulbin, a rookie out of Michigan State, was drafted by the Commanders in the sixth round, 209th overall, in last April's NFL Draft. Gulbin was selected to bring along and provide depth behind starting center Nick Allegretti.
However, on the very first day of the Commanders' 2026 training camp, Allegretti strained a calf. It was a bad enough strain that Allegretti missed nearly three weeks of training camp practices before returning August 18. Wednesday, Allegretti again had to leave practice early after getting injured.
"I think really, just taking it day-by-day, trying to get better every day," is simply how Gulbin replied to Denton Day when asked Wednesday what he is learning through his first NFL training camp. (I am) taking advantage of everything we do, whether it is practice, walkthroughs or meetings, being in tune and locked in with that."
When asked about the offensive line room, Gulbin quickly responded, "I feel like we have a really good group. Coach Stape, Coach Toub and Coach Stolt do a really good job fostering a good brotherhood. They are down-to-earth, salt-of-the-earth guys. Everybody takes care of each other, which I'm super-grateful for." Gulbin was referring to Darnell Stapleton (Offensive Line Coach), Shane Toub (Assistant Offensive Line Coach) and Brian Stoldt (Offensive Quality Control Coach).
#coach #line #training #camp
2 months ago
U.S. Drug Enforcement Agency (DEA) officials are reportedly investigating Hayden Panettiere's death.
On Sunday, the Heroes actress was found unresponsive at an apartment in Greenville, South Carolina and was ******* ounced dead at the scene. She was 36.
At present, officers at the Greenville City Police Department are leading the investigation into Panettiere's sudden passing, but on Wednesday, journalists at ABC News reported that agents at the DEA are "assisting".
Representatives for the DEA and the Panettiere family have not yet commented on the update.
Previously, editors at TMZ claimed Naloxone - a drug that can be used to reverse an opioid overdose - was found at the apartment where the Nashville star died.
In a police report, the officer stated that Panettiere's on-again, off-again boyfriend Brian Hickerson and his brother, Zack Hickerson, were at the residence when emergency services arrived at the scene.
#apartment #scene #agency
On Sunday, the Heroes actress was found unresponsive at an apartment in Greenville, South Carolina and was ******* ounced dead at the scene. She was 36.
At present, officers at the Greenville City Police Department are leading the investigation into Panettiere's sudden passing, but on Wednesday, journalists at ABC News reported that agents at the DEA are "assisting".
Representatives for the DEA and the Panettiere family have not yet commented on the update.
Previously, editors at TMZ claimed Naloxone - a drug that can be used to reverse an opioid overdose - was found at the apartment where the Nashville star died.
In a police report, the officer stated that Panettiere's on-again, off-again boyfriend Brian Hickerson and his brother, Zack Hickerson, were at the residence when emergency services arrived at the scene.
#apartment #scene #agency
2 months ago
LAS VEGAS — Las Vegas Aces head coach Becky Hammon was ejected from her team's matchup against the Atlanta Dream on Tuesday at Michelob Ultra Arena.
The fifth-year coach appeared to be arguing a no-call after Dream forward Angel Reese missed a midrange jumper with 5:06 remaining in the second quarter. That drew Hammon's first technical as the Dream had a 33-29 lead.
Hammon then exited the sideline and charged towards officials on the court in frustration. She had to be held back by her ***** istant coaches and high-fived players and other team personnel as she headed toward the locker room after receiving her second technical foul in quick succession.
Assistant coach Charlene Thomas-Swinson took over in Hammon's absence.
It's Hammon's first ejection since the Aces lost to the Los Angeles Sparks on June 9, 2024.
#vegas #second #technical
The fifth-year coach appeared to be arguing a no-call after Dream forward Angel Reese missed a midrange jumper with 5:06 remaining in the second quarter. That drew Hammon's first technical as the Dream had a 33-29 lead.
Hammon then exited the sideline and charged towards officials on the court in frustration. She had to be held back by her ***** istant coaches and high-fived players and other team personnel as she headed toward the locker room after receiving her second technical foul in quick succession.
Assistant coach Charlene Thomas-Swinson took over in Hammon's absence.
It's Hammon's first ejection since the Aces lost to the Los Angeles Sparks on June 9, 2024.
#vegas #second #technical
2 months ago
Another so-so Zach Wheeler outing was salvaged by the continued August heat wave of Alec Bohm and Bryson Stott as the Philadelphia Phillies (69-58) won their fifth straight game by a score of 6-4 against the Miami Marlins (64-63).
Wheeler gave up two runs across five innings, striking out seven but issuing four walks as 41 of his 98 pitches were called ******* .
Bohm and Stott accounted for a combined three runs scored, three hits and four RBI, aided by a pair of walks issued to Bryce Harper and a trio of hits by Luis Arraez to set the table.
The new corner infield tandem's torrid month included stellar play in the field to go along with the team-carrying offensive production, punctuated by an inning-ending unassisted double play by Bohm to end a threat in the seventh.
The Phillies were down 3-1 against the Marlins' bullpen ******* emblage going into the bottom of the sixth and they came out the other end up 5-3 after sending nine men to the plate.
#bohm #Phillies #runs
Wheeler gave up two runs across five innings, striking out seven but issuing four walks as 41 of his 98 pitches were called ******* .
Bohm and Stott accounted for a combined three runs scored, three hits and four RBI, aided by a pair of walks issued to Bryce Harper and a trio of hits by Luis Arraez to set the table.
The new corner infield tandem's torrid month included stellar play in the field to go along with the team-carrying offensive production, punctuated by an inning-ending unassisted double play by Bohm to end a threat in the seventh.
The Phillies were down 3-1 against the Marlins' bullpen ******* emblage going into the bottom of the sixth and they came out the other end up 5-3 after sending nine men to the plate.
#bohm #Phillies #runs
2 months ago
In their second matchup of a five-game road trip, Caitlin Clark and the Indiana Fever (23-12) travel north of the border on Tuesday night for the first time in franchise history to take on the Toronto Tempo (10-23) from Scotiabank Arena.
While the Fever are seeking their fifth straight win and have won 13 of their past 17 contests, the expansion Tempo have done the opposite in their inaugural season, dropping 10 straight. Indiana toppled Toronto 113-91 in Indianapolis back on June 16 behind a 21-point, 14-assist double-double from Clark.
In Indiana's highly entertaining 95-91 overtime win over the Atlanta Dream on Sunday, Clark led the offensive attack with 26 points and nine **** ists. Sunday's performance sealed the former Hawkeyes' second AP Player of the Week and fourth WNBA Eastern Conference Player of the Week honors, as she averaged 25.7 points and 9.7 **** ists per game on 50.9% shooting across Indiana's three games between Aug. 10-16.
As the Fever and Tempo compete in front of a sold-out ScotiaBank Arena, follow along for live updates and highlights, including Caitlin Clark's latest points and stats.
Watch Indiana Fever at Toronto Tempo
#fever #points #scotiabank #arena
While the Fever are seeking their fifth straight win and have won 13 of their past 17 contests, the expansion Tempo have done the opposite in their inaugural season, dropping 10 straight. Indiana toppled Toronto 113-91 in Indianapolis back on June 16 behind a 21-point, 14-assist double-double from Clark.
In Indiana's highly entertaining 95-91 overtime win over the Atlanta Dream on Sunday, Clark led the offensive attack with 26 points and nine **** ists. Sunday's performance sealed the former Hawkeyes' second AP Player of the Week and fourth WNBA Eastern Conference Player of the Week honors, as she averaged 25.7 points and 9.7 **** ists per game on 50.9% shooting across Indiana's three games between Aug. 10-16.
As the Fever and Tempo compete in front of a sold-out ScotiaBank Arena, follow along for live updates and highlights, including Caitlin Clark's latest points and stats.
Watch Indiana Fever at Toronto Tempo
#fever #points #scotiabank #arena
2 months ago
It's a new week here at BCB After Dark: the grooviest gathering of night owls, early risers, new parents and Cubs fans abroad. We're so glad you decided to stop by. Come on in out of the heat. There's no cover charge. We validate parking. We've got a few tables still available. The hostess will seat you now. Bring your own beverage.
BCB After Dark is the place for you to talk baseball, music, movies, or anything else you need to get off your chest, as long as it is within the rules of the site. The late-nighters are encouraged to get the party started, but everyone else is invited to join in as you wake up the next morning and into the afternoon.
Last week, I asked you who the Cubs second-most valuable player was. The vote wasn't close as 60 percent of you said it was Seiya Suzuki.
Here's the part with the music and the movies. You can do with that what you want.
Saturday was the 101st anniversary of the birth of the great Canadian pianist Oscar Peterson. So to honor Peterson, we have him performing the bossa nova classic "Wave" with guitarist Joe Pass and bassist Niels-Henning Ørsted Pedersen (NHØP) in Italy in 1985.
#dark #else #come #we 've
BCB After Dark is the place for you to talk baseball, music, movies, or anything else you need to get off your chest, as long as it is within the rules of the site. The late-nighters are encouraged to get the party started, but everyone else is invited to join in as you wake up the next morning and into the afternoon.
Last week, I asked you who the Cubs second-most valuable player was. The vote wasn't close as 60 percent of you said it was Seiya Suzuki.
Here's the part with the music and the movies. You can do with that what you want.
Saturday was the 101st anniversary of the birth of the great Canadian pianist Oscar Peterson. So to honor Peterson, we have him performing the bossa nova classic "Wave" with guitarist Joe Pass and bassist Niels-Henning Ørsted Pedersen (NHØP) in Italy in 1985.
#dark #else #come #we 've
2 months ago
Kelly Macdonald is back on our screens in HBO's new series, Lanterns, an eight-part superhero drama set in the DC Universe. The Scottish actress plays Sheriff Kerry in the anticipated new show, which follows two intergalactic cops as they investigate a murder in a small town in Nebraska.
The 50-year-old boasts an impressive TV and film career, with credits including Line of Duty, Operation Mincemeat, Trainspotting and Dept. Q. But did you know that her ex-husband is also a famous face? Keep reading to find out more about Kelly's home life…
Kelly Macdonald stars as Sheriff Kerry in Lanterns (@ John Johnson/HBO Max)
Kelly was married to Scottish musician Douglas Payne, the bassist in the rock band Travis, for 14 years.
Kelly was previously married to musician Dougie Payne (@ Brad Barket/Getty Images)
#kelly #payne #musician
The 50-year-old boasts an impressive TV and film career, with credits including Line of Duty, Operation Mincemeat, Trainspotting and Dept. Q. But did you know that her ex-husband is also a famous face? Keep reading to find out more about Kelly's home life…
Kelly Macdonald stars as Sheriff Kerry in Lanterns (@ John Johnson/HBO Max)
Kelly was married to Scottish musician Douglas Payne, the bassist in the rock band Travis, for 14 years.
Kelly was previously married to musician Dougie Payne (@ Brad Barket/Getty Images)
#kelly #payne #musician